Shares of Structure Therapeutics Inc. (NASDAQ:GPCR – Get Free Report) have been assigned an average recommendation of “Buy” from the six research firms that are presently covering the firm, Marketbeat reports. Six equities research analysts have rated the stock with a buy rating. The average 12-month target price among brokers that have issued a report […]

Shares of Trupanion, Inc. (NASDAQ:TRUP – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the seven analysts that are presently covering the firm, MarketBeat Ratings reports. Three analysts have rated the stock with a hold rating, three have issued a buy rating and one has issued a strong buy rating […]